Surgery is rarely indicated in these circumstances. Infrequently, benign liver tumors are diagnosed because of symptoms or complications, and require urgent management including surgery as a major ...

Long classified as a subset of common liver cancer, FLC should be considered its own unique disease. Now researchers are testing a combination drug therapy that targets FLC tumors.

FLC is a rare liver cancer with unique genetic traits, often misdiagnosed until advanced. New research and a clinical trial ...

Salk scientists have found that eliminating the bile acid-producing protein BAAT and supplementing with the bile acid UDCA ...

T-cells from the liver and lymph nodes show promising potential for future treatments of liver cancer, according to a new ...

New insights into fibrolamellar hepatocellular carcinoma could lead to new drugs and significantly improved health outcomes.

T-cells from the liver and lymph nodes show promising potential for future treatments of liver cancer, according to a new ...

While studying mouse and human liver tumors, they discovered that certain bile acids in the liver could affect the activity of cancer-fighting immune cells, called T cells. The researchers ...